191 related articles for article (PubMed ID: 8187650)
21. Characterization and regulation of the receptor tyrosine kinase Tie-1 in platelets.
Tsiamis AC; Hayes P; Box H; Goodall AH; Bell PR; Brindle NP
J Vasc Res; 2000; 37(6):437-42. PubMed ID: 11146396
[TBL] [Abstract][Full Text] [Related]
22. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells.
Hayes AJ; Huang WQ; Mallah J; Yang D; Lippman ME; Li LY
Microvasc Res; 1999 Nov; 58(3):224-37. PubMed ID: 10527766
[TBL] [Abstract][Full Text] [Related]
23. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response.
Korpelainen EI; Kärkkäinen M; Gunji Y; Vikkula M; Alitalo K
Oncogene; 1999 Jan; 18(1):1-8. PubMed ID: 9926914
[TBL] [Abstract][Full Text] [Related]
24. Endothelial-specific gene expression directed by the tie gene promoter in vivo.
Korhonen J; Lahtinen I; Halmekytö M; Alhonen L; Jänne J; Dumont D; Alitalo K
Blood; 1995 Sep; 86(5):1828-35. PubMed ID: 7655012
[TBL] [Abstract][Full Text] [Related]
25. Role of ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter.
Iljin K; Dube A; Kontusaari S; Korhonen J; Lahtinen I; Oettgen P; Alitalo K
FASEB J; 1999 Feb; 13(2):377-86. PubMed ID: 9973326
[TBL] [Abstract][Full Text] [Related]
26. Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells.
Hashiyama M; Iwama A; Ohshiro K; Kurozumi K; Yasunaga K; Shimizu Y; Masuho Y; Matsuda I; Yamaguchi N; Suda T
Blood; 1996 Jan; 87(1):93-101. PubMed ID: 8547681
[TBL] [Abstract][Full Text] [Related]
27. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling.
Goldman-Wohl DS; Ariel I; Greenfield C; Lavy Y; Yagel S
Mol Hum Reprod; 2000 Jan; 6(1):81-7. PubMed ID: 10611265
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells.
Yano M; Iwama A; Nishio H; Suda J; Takada G; Suda T
Blood; 1997 Jun; 89(12):4317-26. PubMed ID: 9192754
[TBL] [Abstract][Full Text] [Related]
29. flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors.
Yamaguchi TP; Dumont DJ; Conlon RA; Breitman ML; Rossant J
Development; 1993 Jun; 118(2):489-98. PubMed ID: 8223275
[TBL] [Abstract][Full Text] [Related]
30. Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation.
Yuan HT; Suri C; Yancopoulos GD; Woolf AS
J Am Soc Nephrol; 1999 Aug; 10(8):1722-36. PubMed ID: 10446940
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells.
Iwama A; Hamaguchi I; Hashiyama M; Murayama Y; Yasunaga K; Suda T
Biochem Biophys Res Commun; 1993 Aug; 195(1):301-9. PubMed ID: 8395828
[TBL] [Abstract][Full Text] [Related]
32. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
33. Potential roles of metalloprotease mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1.
McCarthy MJ; Burrows R; Bell SC; Christie G; Bell PR; Brindle NP
Lab Invest; 1999 Jul; 79(7):889-95. PubMed ID: 10418829
[TBL] [Abstract][Full Text] [Related]
34. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R.
Jones N; Dumont DJ
Oncogene; 1998 Sep; 17(9):1097-108. PubMed ID: 9764820
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas.
Kaipainen A; Vlaykova T; Hatva E; Böhling T; Jekunen A; Pyrhönen S; Alitalo K
Cancer Res; 1994 Dec; 54(24):6571-7. PubMed ID: 7987857
[TBL] [Abstract][Full Text] [Related]
36. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat.
Beck H; Acker T; Wiessner C; Allegrini PR; Plate KH
Am J Pathol; 2000 Nov; 157(5):1473-83. PubMed ID: 11073808
[TBL] [Abstract][Full Text] [Related]
37. Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium.
Rajantie I; Ekman N; Iljin K; Arighi E; Gunji Y; Kaukonen J; Palotie A; Dewerchin M; Carmeliet P; Alitalo K
Mol Cell Biol; 2001 Jul; 21(14):4647-55. PubMed ID: 11416142
[TBL] [Abstract][Full Text] [Related]
38. Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development.
Dube A; Thai S; Gaspar J; Rudders S; Libermann TA; Iruela-Arispe L; Oettgen P
Circ Res; 2001 Feb; 88(2):237-44. PubMed ID: 11157678
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning, expression and partial characterization of Xksy, Xenopus member of the Sky family of receptor tyrosine kinases.
Kishi YA; Funakoshi H; Matsumoto K; Nakamura T
Gene; 2002 Apr; 288(1-2):29-40. PubMed ID: 12034491
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation.
Yabkowitz R; Meyer S; Black T; Elliott G; Merewether LA; Yamane HK
Blood; 1999 Mar; 93(6):1969-79. PubMed ID: 10068670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
